🔴 Opus Genetics is trading 5.4% down today as crude and Treasury yields pressure growth stocks

Opus Genetics is trading 5.4% lower at $4.88 as weaker risk sentiment across U.S. equities weighs on shares.

• The Nasdaq Composite is down 1.00%; higher crude oil prices and Treasury yields are pressuring growth-stock valuations.
• No fresh company-specific announcement was identified for September 23, 2026.
• The latest major update was positive Phase 1/2 OPGx-BEST1 data and an FDA Type C meeting announced September 9; global market pressure is the likelier explanation.